Seroprevalence of IgG antibodies against 13 vaccine Streptococcus pneumoniae serotypes in the Netherlands

Vaccine

Volumn 29, Issue 5, 2011, Pages 1029-1035

  Elberse, K E M ^a   de Greeff, S C ^a   Wattimena, N ^a   Chew, W ^a   Schot, C S ^a   van de Pol, J E ^a   van der Heide, J G J ^a   van der Ende, A ^b   van der Klis, F R M ^a   Berbers, G A M ^a   Schouls, L M ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Multiplex immuno assay; Pneumococcus; Seroprevalence

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; PNEUMOCOCCUS VACCINE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANTIBODY BLOOD LEVEL; ARTICLE; BLOOD ANALYSIS; BLOOD BANK; CHILD; CONTROLLED STUDY; FEMALE; HUMAN; IMMIGRANT; IMMUNOASSAY; INFANT; MALE; NETHERLANDS; NEWBORN; PNEUMOCOCCAL INFECTION; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SEROPREVALENCE; SEROTYPE; VACCINATION;

ADOLESCENT; ADULT; AGED; ANTIBODIES, BACTERIAL; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; IMMUNOGLOBULIN G; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; NETHERLANDS; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; SEROEPIDEMIOLOGIC STUDIES; STREPTOCOCCUS PNEUMONIAE; YOUNG ADULT;

EID: 78751584973     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.11.054     Document Type: Article

References (25)

1. Jansen A.G., Rodenburg G.D., de Greeff S.C., Hak E., Veenhoven R.H., Spanjaard L., et al. Invasive pneumococcal disease in the Netherlands: syndromes, outcome and potential vaccine benefits. Vaccine 2009, 27(17):2394-2401.
2. Shahid N.S., Steinhoff M.C., Hoque S.S., Begum T., Thompson C., Siber G.R. Serum, breast milk, and infant antibody after maternal immunisation with pneumococcal vaccine. Lancet 1995, 346(November (8985)):1252-1257.
3. Brussow H., Baensch M., Sidoti J. Seroprevalence of immunoglobulin M (IgM) and IgG antibodies to polysaccharides of Streptococcus pneumoniae in different age groups of Ecuadorian and German children. J Clin Microbiol 1992, 30(November (11)):2765-2771.
4. Balmer P., Borrow R., Findlow J., Warrington R., Frankland S., Waight P., et al. Age-stratified prevalences of pneumococcal-serotype-specific immunoglobulin G in England and their relationship to the serotype-specific incidence of invasive pneumococcal disease prior to the introduction of the pneumococcal 7-valent conjugate vaccine. Clin Vaccine Immunol 2007, 14(November (11)):1442-1450.
5. Sims R.V., Boyko E.J., Maislin G., Lipsky B.A., Schwartz J.S. The role of age in susceptibility to pneumococcal infections. Age Ageing 1992, 21(September (5)):357-361.
6. van der Klis F.R., Mollema L., Berbers G.A., de Melker H.E., Coutinho R.A. Second national serum bank for population-based seroprevalence studies in the Netherlands. Neth J Med 2009, 67(July-August (7)):301-308.
7. Rodenburg G.D., de Greeff S.C., Jansen A.G., de Melker H.E., Schouls L.M., Hak E., et al. Effects of pneumococcal conjugate vaccine 2 years after its introduction, the Netherlands. Emerg Infect Dis 2010, 16(May (5)):816-823.
8. Elberse K.E., Tcherniaeva I., Berbers G.A., Schouls L.M. Optimization and application of a 13-plex bead based assay to quantify serotype specific IgG against Streptococcus pneumoniae polysaccharides: response to the booster vaccine after immunization with PCV-7. Clin Vaccine Immunol 2010, 17(February (4)):674.
9. Gottschalk P.G., Dunn J.R. The five-parameter logistic: a characterization and comparison with the four-parameter logistic. Anal Biochem 2005, 343(1):54-65.
10. Prentice R.L. A generalization of the probit and logit methods for dose response curves. Biometrics 1976, 32(4):761-768.
11. Bogaert D., van Belkum A., Sluijter M., Luijendijk A., de Groot R., Rumke H.C., et al. Colonisation by Streptococcus pneumoniae and Staphylococcus aureus in healthy children. Lancet 2004, 363(June (9424)):1871-1872.
12. Brueggemann A.B., Griffiths D.T., Meats E., Peto T., Crook D.W., Spratt B.G. Clonal relationships between invasive and carriage Streptococcus pneumoniae and serotype- and clone-specific differences in invasive disease potential. J Infect Dis 2003, 187(May (9)):1424-1432.
13. Hussain M., Melegaro A., Pebody R.G., George R., Edmunds W.J., Talukdar R., et al. A longitudinal household study of Streptococcus pneumoniae nasopharyngeal carriage in a UK setting. Epidemiol Infect 2005, 133(October (5)):891-898.
14. Soininen A., Pursiainen H., Kilpi T., Kayhty H. Natural development of antibodies to pneumococcal capsular polysaccharides depends on the serotype: association with pneumococcal carriage and acute otitis media in young children. J Infect Dis 2001, 184(September (5)):569-576.
15. Bogaert D., Engelen M.N., Timmers-Reker A.J., Elzenaar K.P., Peerbooms P.G., Coutinho R.A., et al. Pneumococcal carriage in children in The Netherlands: a molecular epidemiological study. J Clin Microbiol 2001, 39(September (9)):3316-3320.
16. Goldblatt D., Southern J., Ashton L., Richmond P., Burbidge P., Tasevska J., et al. Immunogenicity and boosting after a reduced number of doses of a pneumococcal conjugate vaccine in infants and toddlers. Pediatr Infect Dis J 2006, 25(4):312-319.
17. Esposito S., Pugni L., Bosis S., Proto A., Cesati L., Bianchi C., et al. Immunogenicity, safety and tolerability of heptavalent pneumococcal conjugate vaccine administered at 3, 5 and 11 months post-natally to pre- and full-term infants. Vaccine 2005, 23(February (14)):1703-1708.
18. Syrjanen R.K., Kilpi T.M., Kaijalainen T.H., Herva E.E., Takala A.K. Nasopharyngeal carriage of Streptococcus pneumoniae in Finnish children younger than 2 years old. J Infect Dis 2001, 184(August (4)):451-459.
19. Wadowsky R.M., Mietzner S.M., Skoner D.P., Doyle W.J., Fireman P. Effect of experimental influenza A virus infection on isolation of Streptococcus pneumoniae and other aerobic bacteria from the oropharynges of allergic and nonallergic adult subjects. Infect Immun 1995, 63(April (4)):1153-1157.
20. Borgers H., Jeurissen A., Flamaing J., Peetermans W.E., Moens L., Verhaegen J., et al. Elderly subjects do not show impaired pneumococcal capsular polysaccharide serotype-specific antibody responses as assessed by a multiplexed bead assay. Clin Immunol 2010, 135(June (3)):501-502.
21. Sankilampi U., Honkanen P.O., Bloigu A., Herva E., Leinonen M. Antibody response to pneumococcal capsular polysaccharide vaccine in the elderly. J Infect Dis 1996, 173(February (2)):387-393.
22. Simell B., Lahdenkari M., Reunanen A., Kayhty H., Vakevainen M. Effects of ageing and gender on naturally acquired antibodies to pneumococcal capsular polysaccharides and virulence-associated proteins. Clin Vaccine Immunol 2008, 15(September (9)):1391-1397.
23. Lee H., Nahm M.H., Kim K.H. The effect of age on the response to the pneumococcal polysaccharide vaccine. BMC Infect Dis 2010, 10:60.
24. Shapiro E.D., Berg A.T., Austrian R., Schroeder D., Parcells V., Margolis A., et al. The protective efficacy of polyvalent pneumococcal polysaccharide vaccine. N Engl J Med 1991, 325(November (21)):1453-1460.
25. Romero-Steiner S., Frasch C.E., Carlone G., Fleck R.A., Goldblatt D., Nahm M.H. Use of opsonophagocytosis for serological evaluation of pneumococcal vaccines. Clin Vaccine Immunol 2006, 13(February (2)):165-169.